Brazilian Journal of Psychiatry · 2015 · 19 citations · 23 references
MedicineNeurologyOncologyNeuro-oncologyPsychiatric AssessmentPsychoneuroimmunologyBiomarker ValidationDelirium AssessmentDelirium Assessment ScalesDelirium BiomarkersDelirium EtiologyDigit Span TestDisease BiomarkersMental State Examination
OBJECTIVE: To evaluate brain-derived neurotrophic factor (BDNF) and tumor necrosis factor-α (TNF-α) blood levels as disease biomarkers of delirium in oncology inpatients. METHODS: Seventeen oncology inpatients with delirium, 28 oncology inpatients without delirium, and 25 non-oncology controls (caregivers) were consecutively recruited from a Brazilian cancer center. This sample was matched by age, sex, and education level. The Confusion Assessment Method, the Mini-Mental State Examination, and the Digit Span Test were administered to ascertain delirium diagnosis. BDNF and TNF-α levels were measured by the Sandwich-ELISA method and flow cytometry, respectively. Blood samples were collected immediately after clinical evaluation. RESULTS: Oncology inpatients (with and without delirium) showed significantly lower BDNF levels compared with non-oncology controls (F = 13.830; p = 0.001). TNF-α levels did not differ between the three groups. CONCLUSION: A cross-sectional relationship of BDNF and TNF-α blood levels with delirium in oncology inpatients was not demonstrated. The association between cancer and reduced serum BDNF levels may be mediated by confounding factors.
23
Clarifying Confusion: The Confusion Assessment Method
Sharon K. Inouye · Annals of Internal Medicine · 1990 · 5.3K citations
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Liya Qin, Xuefei Wu, Michelle L. Block et al. · Glia · 2007 · 2.2K citations · Full text